Salim Syed analyst MIZUHO

Currently out of the existing stock ratings of Salim Syed, 209 are a BUY (82.94%), 43 are a HOLD (17.06%).

Salim Syed

Work Performance Price Targets & Ratings Chart

Analyst Salim Syed, currently employed at MIZUHO, has had 59.75% of price targets met with an average potential upside of 47.61%, reached in 306 days on average.

Salim Syed has documented 490 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ASMB, Assembly Biosciences at 01-Sep-2026.

Wall Street Analyst Salim Syed

Analyst best performing recommendations are on UBX (UNITY BIOTECHNOLOGY).
The best stock recommendation documented was for BBIO (BRIDGEBIO PHARMA) on 7/10/2023. The price target of $29 was fulfilled within 7 days with a profit of $11.64 (67.05%), with a performance score of 95.79.

Average potential price target upside

AMGN Amgen ASMB Assembly Biosciences BBIO BridgeBio Pharma BIIB Biogen BMY Bristol-Myers Squibb Company CELG Celgene CYTK Cytokinetics GILD Gilead Sciences NKTX Nkarta UBX Unity Biotechnology WVE Wave Life Sciences Ltd ATRA Atara Biotherapeutics CHRS Coherus BioSciences CRSP Crispr Therapeutics AG PCVX Vaxcyte ELVN Enliven Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Jan-2025

$542

$103.18 (23.51%)

$457

1 days ago
(18-Nov-2026)

Hold Since 21-Feb-2026

$430

$-8.82 (-2.01%)

$400

4 days ago
(15-Nov-2026)

Buy Since 05-Feb-2023

$515

$76.18 (17.36%)

$460

8 days ago
(11-Nov-2026)

4/5 (80%)

$47.94 (10.26%)

163

Hold Since 19-May-2025

$435

$-3.82 (-0.87%)

$388

15 days ago
(04-Nov-2026)

6/8 (75%)

$-25.28 (-5.49%)

41

Buy Since 27-Apr-2023

$536

$97.18 (22.15%)

$370

16 days ago
(03-Nov-2026)

3/4 (75%)

$57.52 (12.02%)

467

Show more analysts

Please expand the browser size to see the chart

Which stock is Salim Syed most bullish on?

Potential upside of $99.63 has been obtained for PCVX (VAXCYTE)

Which stock is Salim Syed most reserved on?

Potential downside of -$86.82 has been obtained for AMGN (AMGEN)

What Year was the first public recommendation made by Salim Syed?

On 2016
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?